11/07/2008 (Agence Europe) - The European Investment Bank (EIB) has granted B. Braun Melsungen AG (BBM) a loan of up to €125 million to expand its research infrastructure and develop innovative pharmaceutical products and production processes over the period 2008-2010. Facilities including a central laboratory and pharmaceutical clean rooms will be built at the firm's headquarters in Melsungen (Hessen). The EIB says that this investment will further strengthen BBM's position in the...